Article Text

Download PDFPDF
CASE REPORT
Paediatric severe chronic spontaneous urticaria: successful management through conventional drug therapy
  1. Dimitri Poddighe1,2,
  2. Ilaria Brambilla2,3,
  3. Amelia Licari2,3 and
  4. Gian Luigi Marseglia2,3
  1. 1 Department of Medicine, Nazarbayev University School of Medicine, Nur-Sultan City, Kazakhstan
  2. 2 Department of Pediatrics, Universita' degli Studi, Pavia, Italy
  3. 3 Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
  1. Correspondence to Professor Gian Luigi Marseglia, gl.marseglia{at}smatteo.pv.it

Abstract

Chronic spontaneous urticaria (CSU) can occur in children and the clinical management is quite challenging. Here, we described a paediatric clinical case of CSU successfully managed by conventional therapy, including systemic steroids, cetirizine, anti-leukotriene drug and dietary restriction (for histamine-releasing foods). This patient showed neither atopy nor any allergic sensitisation; moreover, the autologous serum skin test resulted negative. This category of patients with no comorbidity and no evidence of atopy might benefit from the conventional drug management; however, a protracted course of steroid treatment with very slow and gradual tapering may be needed. This approach was successful and safe in our clinical case, but a careful follow-up, due to the potential side effects of steroids, should be recommended.

  • paediatrics (drugs and medicines)
  • medical management
  • dermatology

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors DP managed the patient. DP conceived and wrote the article. AL and IB helped in writing the article. GLM provided intellectual contribution.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.